{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:28:46Z","timestamp":1789759726971,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Two risk factors for severe retinopathy of prematurity (ROP) in extremely preterm infants are thrombocytopenia and low levels of arachidonic acid (AA) and docosahexaenoic acid (DHA). To date, these risk factors have not been linked.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>Infants born &lt;\u200928 weeks gestational age (GA) from 2016 to 2019 were randomized to postnatal enteral AA\/DHA supplementation or standard care (controls). Levels of AA and DHA, platelet counts (\u2009&lt;\u2009100\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L defined as thrombocytopenia) and platelet-related proteins in the infants\u2019 first four weeks of life were evaluated for their association with severe ROP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean birthweight of 178 included infants was 806\u2009\u00b1\u2009200 grams, and the mean GA was 25.6\u2009\u00b1\u20091.4 weeks. During the first four postnatal weeks, 20.2% of AA\/DHA-supplemented infants had thrombocytopenia versus 27.7% of controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.29). In infants with thrombocytopenia, fewer AA\/DHA-supplemented infants developed severe ROP than non-supplemented controls, 29.4% (5\/17) versus 65.4% (17\/26) (<jats:italic>p<\/jats:italic>\u2009=\u20090.031). Thrombocytopenia and serum levels of AA and DHA correlated with several platelet-related proteins involved in angiogenesis and ROP, such as platelet-derived growth factor subunits A and B and vascular endothelial growth factor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>AA and DHA supplementation is associated with less severe ROP in thrombocytopenic infants, possibly by modulating platelet activation and function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Impact<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Postnatal enteral supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) to extremely preterm infants reduces the risk of severe retinopathy of prematurity (ROP) in infants with thrombocytopenia. The impact of AA and DHA might be, at least in part, mediated through altered platelet activation.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>We found that AA and DHA may reduce the risk of severe ROP, possibly by modulating platelet-related proteins involved in angiogenesis.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Our findings strongly support that supplementing AA and DHA to extremely preterm infants is crucial and can significantly impact their health.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41390-024-03775-3","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:52:01Z","timestamp":1734612721000},"page":"680-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Platelet characteristics in extremely preterm infants after fatty acid supplementation: a randomized controlled trial"],"prefix":"10.1038","volume":"98","author":[{"given":"Pia","family":"Lundgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldina","family":"Pivodic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders K.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnel","family":"Hellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Wackernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Hansen","family":"Pupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"S\u00e4vman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Uhl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois E. H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"Suppl 1","key":"3775_CR1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe, H., Lawn, J. E., Vazquez, T., Fielder, A. & Gilbert, C. Preterm-Associated Visual Impairment and Estimates of Retinopathy of Prematurity at Regional and Global Levels for 2010. Pediatr. Res 74(Suppl 1), 35\u201349 (2013).","journal-title":"Pediatr. Res"},{"key":"3775_CR2","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","volume":"15","author":"J Stone","year":"1995","unstructured":"Stone, J. et al. Development of Retinal Vasculature Is Mediated by Hypoxia-Induced Vascular Endothelial Growth Factor (Vegf) Expression by Neuroglia. J. Neurosci. 15, 4738\u20134747 (1995).","journal-title":"J. Neurosci."},{"key":"3775_CR3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","volume":"125","author":"LE Benjamin","year":"1998","unstructured":"Benjamin, L. E., Hemo, I. & Keshet, E. A Plasticity Window for Blood Vessel Remodelling Is Defined by Pericyte Coverage of the Preformed Endothelial Network and Is Regulated by Pdgf-B and Vegf. Development 125, 1591\u20131598 (1998).","journal-title":"Development"},{"key":"3775_CR4","doi-asserted-by":"crossref","unstructured":"Cakir, B. et al. Thrombocytopenia Is Associated with Severe Retinopathy of Prematurity. JCI Insight 3, e99448 (2018).","DOI":"10.1172\/jci.insight.99448"},{"key":"3775_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaapos.2017.11.009","volume":"22","author":"AK Jensen","year":"2018","unstructured":"Jensen, A. K., Ying, G. S., Huang, J., Quinn, G. E. & Binenbaum, G. Longitudinal Study of the Association between Thrombocytopenia and Retinopathy of Prematurity. J. aapos 22, 119\u2013123 (2018).","journal-title":"J. aapos"},{"key":"3775_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000448161","volume":"111","author":"P Lundgren","year":"2017","unstructured":"Lundgren, P. et al. Aggressive Posterior Retinopathy of Prematurity Is Associated with Multiple Infectious Episodes and Thrombocytopenia. Neonatology 111, 79\u201385 (2017).","journal-title":"Neonatology"},{"key":"3775_CR7","doi-asserted-by":"crossref","unstructured":"Parrozzani, R. et al. Thrombocytopenia as Type 1 Rop Biomarker: A Longitudinal Study. J. Pers. Med. 11, 1120 (2021).","DOI":"10.3390\/jpm11111120"},{"key":"3775_CR8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","volume":"111","author":"JE Italiano Jr","year":"2008","unstructured":"Italiano, J. E. Jr et al. Angiogenesis Is Regulated by a Novel Mechanism: Pro- and Antiangiogenic Proteins Are Organized into Separate Platelet Alpha Granules and Differentially Released. Blood 111, 1227\u20131233 (2008).","journal-title":"Blood"},{"key":"3775_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000512282","volume":"118","author":"G Hellgren","year":"2021","unstructured":"Hellgren, G. et al. Decreased Platelet Counts and Serum Levels of Vegf-a, Pdgf-Bb, and Bdnf in Extremely Preterm Infants Developing Severe Rop. Neonatology 118, 18\u201327 (2021).","journal-title":"Neonatology"},{"key":"3775_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","volume":"23","author":"P Blair","year":"2009","unstructured":"Blair, P. & Flaumenhaft, R. Platelet Alpha-Granules: Basic Biology and Clinical Correlates. Blood Rev. 23, 177\u2013189 (2009).","journal-title":"Blood Rev."},{"key":"3775_CR11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00431-018-3153-7","volume":"177","author":"E Resch","year":"2018","unstructured":"Resch, E., Hinkas, O., Urlesberger, B. & Resch, B. Neonatal Thrombocytopenia-Causes and Outcomes Following Platelet Transfusions. Eur. J. Pediatr. 177, 1045\u20131052 (2018).","journal-title":"Eur. J. Pediatr."},{"key":"3775_CR12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1203\/00006450-199801000-00023","volume":"43","author":"NA Murray","year":"1998","unstructured":"Murray, N. A., Watts, T. L. & Roberts, I. A. Endogenous Thrombopoietin Levels and Effect of Recombinant Human Thrombopoietin on Megakaryocyte Precursors in Term and Preterm Babies. Pediatr. Res 43, 148\u2013151 (1998).","journal-title":"Pediatr. Res"},{"key":"3775_CR13","doi-asserted-by":"crossref","first-page":"F359","DOI":"10.1136\/fn.88.5.F359","volume":"88","author":"I Roberts","year":"2003","unstructured":"Roberts, I. & Murray, N. A. Neonatal Thrombocytopenia: Causes and Management. Arch. Dis. Child Fetal Neonatal Ed. 88, F359\u2013F364 (2003).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"3775_CR14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation.V2012.1.506.3798532","volume":"2012","author":"M Sola-Visner","year":"2012","unstructured":"Sola-Visner, M. Platelets in the Neonatal Period: Developmental Differences in Platelet Production, Function, and Hemostasis and the Potential Impact of Therapies. Hematol. Am. Soc. Hematol. Educ. Program 2012, 506\u2013511 (2012).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"3775_CR15","doi-asserted-by":"crossref","unstructured":"Weiss, L. J. et al. Ontogenesis of Functional Platelet Subpopulations from Preterm and Term Neonates to Adulthood: The Plinius Study. Blood Adv. 7, 4334\u20134348 (2023).","DOI":"10.1182\/bloodadvances.2023009824"},{"key":"3775_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.thromres.2008.10.004","volume":"124","author":"FJ Bednarek","year":"2009","unstructured":"Bednarek, F. J., Bean, S., Barnard, M. R., Frelinger, A. L. & Michelson, A. D. The Platelet Hyporeactivity of Extremely Low Birth Weight Neonates Is Age-Dependent. Thromb. Res 124, 42\u201345 (2009).","journal-title":"Thromb. Res"},{"key":"3775_CR17","doi-asserted-by":"crossref","first-page":"e12751","DOI":"10.1002\/rth2.12751","volume":"6","author":"NT Hovgesen","year":"2022","unstructured":"Hovgesen, N. T., Hviid, C. V. B., Grevsen, A. K., Hansen, A. K. & Hvas, A. M. Reduced Platelet Function in Preterm Neonates Compared with Term Neonates. Res Pr. Thromb. Haemost. 6, e12751 (2022).","journal-title":"Res Pr. Thromb. Haemost."},{"key":"3775_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11745-003-1065-1","volume":"38","author":"MA Crawford","year":"2003","unstructured":"Crawford, M. A. et al. The Potential Role for Arachidonic and Docosahexaenoic Acids in Protection against Some Central Nervous System Injuries in Preterm Infants. Lipids 38, 303\u2013315 (2003).","journal-title":"Lipids"},{"key":"3775_CR19","volume":"11","author":"Z Fu","year":"2019","unstructured":"Fu, Z. et al. Dyslipidemia in Retinal Metabolic Disorders. EMBO Mol. Med 11, e10473 (2019).","journal-title":"EMBO Mol. Med"},{"key":"3775_CR20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/15384101.2017.1312233","volume":"16","author":"A Dhenge","year":"2017","unstructured":"Dhenge, A., Limbkar, K., Melinkeri, S., Kale, V. P. & Limaye, L. Arachidonic Acid and Docosahexanoic Acid Enhance Platelet Formation from Human Apheresis-Derived Cd34(+) Cells. Cell Cycle 16, 979\u2013990 (2017).","journal-title":"Cell Cycle"},{"key":"3775_CR21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.114.301597","volume":"114","author":"VB O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell, V. B., Murphy, R. C. & Watson, S. P. Platelet Lipidomics: Modern Day Perspective on Lipid Discovery and Characterization in Platelets. Circ. Res 114, 1185\u20131203 (2014).","journal-title":"Circ. Res"},{"key":"3775_CR22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00109-017-1542-4","volume":"95","author":"J Yeung","year":"2017","unstructured":"Yeung, J., Hawley, M. & Holinstat, M. The Expansive Role of Oxylipins on Platelet Biology. J. Mol. Med (Berl.) 95, 575\u2013588 (2017).","journal-title":"J. Mol. Med (Berl.)"},{"key":"3775_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00009-9","volume":"105","author":"C Krishnamurti","year":"2002","unstructured":"Krishnamurti, C., Stewart, M. W., Cutting, M. A. & Rothwell, S. W. Assessment of Omega-Fatty-Acid-Supplemented Human Platelets for Potential Improvement in Long-Term Storage. Thromb. Res 105, 139\u2013145 (2002).","journal-title":"Thromb. Res"},{"key":"3775_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.prostaglandins.2018.09.005","volume":"139","author":"R Adili","year":"2018","unstructured":"Adili, R., Hawley, M. & Holinstat, M. Regulation of Platelet Function and Thrombosis by Omega-3 and Omega-6 Polyunsaturated Fatty Acids. Prostaglandins Other Lipid Mediat 139, 10\u201318 (2018).","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"3775_CR25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","volume":"201","author":"KR Machlus","year":"2013","unstructured":"Machlus, K. R. & Italiano, J. E. Jr The Incredible Journey: From Megakaryocyte Development to Platelet Formation. J. Cell Biol. 201, 785\u2013796 (2013).","journal-title":"J. Cell Biol."},{"key":"3775_CR26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0022-3476(72)80539-0","volume":"81","author":"MD Caldwell","year":"1972","unstructured":"Caldwell, M. D., Jonsson, H. T. & Othersen, H. B. Jr Essential Fatty Acid Deficiency in an Infant Receiving Prolonged Parenteral Alimentation. J. Pediatr. 81, 894\u2013898 (1972).","journal-title":"J. Pediatr."},{"key":"3775_CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3476(77)80712-9","volume":"90","author":"Z Friedman","year":"1977","unstructured":"Friedman, Z., Lamberth, E. L. Jr, Stahlman, M. T. & Oates, J. A. Platelet Dysfunction in the Neonate with Essential Fatty Acid Deficiency. J. Pediatr. 90, 439\u2013443 (1977).","journal-title":"J. Pediatr."},{"key":"3775_CR28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapediatrics.2020.5653","volume":"175","author":"A Hellstr\u00f6m","year":"2021","unstructured":"Hellstr\u00f6m, A. et al. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial. JAMA Pediatr. 175, 359\u2013367 (2021).","journal-title":"JAMA Pediatr."},{"key":"3775_CR29","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.clnu.2023.04.020","volume":"42","author":"U Sj\u00f6bom","year":"2023","unstructured":"Sj\u00f6bom, U. et al. Modification of Serum Fatty Acids in Preterm Infants by Parenteral Lipids and Enteral Docosahexaenoic Acid\/Arachidonic Acid: A Secondary Analysis of the Mega Donna Mega Trial. Clin. Nutr. 42, 962\u2013971 (2023).","journal-title":"Clin. Nutr."},{"key":"3775_CR30","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jpeds.2012.11.052","volume":"162","author":"A Lapillonne","year":"2013","unstructured":"Lapillonne, A., Groh-Wargo, S., Gonzalez, C. H. & Uauy, R. Lipid Needs of Preterm Infants: Updated Recommendations. J. Pediatr. 162, S37\u2013S47 (2013).","journal-title":"J. Pediatr."},{"key":"3775_CR31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile, L. A., Burstein, J., Burstein, R. & Koffler, H. Incidence and Evolution of Subependymal and Intraventricular Hemorrhage: A Study of Infants with Birth Weights Less Than 1500 Gm. J. Pediatr. 92, 529\u2013534 (1978).","journal-title":"J. Pediatr."},{"key":"3775_CR32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity.","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity Revisited. Arch. Ophthalmol. 123, 991\u2013999 (2005).","journal-title":"Arch. Ophthalmol."},{"key":"3775_CR33","doi-asserted-by":"crossref","unstructured":"Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial. Arch. Ophthalmol. 121, 1684\u20131694 (2003).","DOI":"10.1001\/archopht.121.12.1684"},{"key":"3775_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clnesp.2017.04.004","volume":"20","author":"S Najm","year":"2017","unstructured":"Najm, S. et al. Effects of a Lipid Emulsion Containing Fish Oil on Polyunsaturated Fatty Acid Profiles, Growth and Morbidities in Extremely Premature Infants: A Randomized Controlled Trial. Clin. Nutr. ESPEN 20, 17\u201323 (2017).","journal-title":"Clin. Nutr. ESPEN"},{"key":"3775_CR35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s43856-023-00338-1","volume":"3","author":"W Zhong","year":"2023","unstructured":"Zhong, W. et al. The Development of Blood Protein Profiles in Extremely Preterm Infants Follows a Stereotypic Evolution Pattern. Commun. Med (Lond.) 3, 107 (2023).","journal-title":"Commun. Med (Lond.)"},{"key":"3775_CR36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41390-021-01528-0","volume":"91","author":"H Danielsson","year":"2022","unstructured":"Danielsson, H. et al. Blood Protein Profiles Related to Preterm Birth and Retinopathy of Prematurity. Pediatr. Res 91, 937\u2013946 (2022).","journal-title":"Pediatr. Res"},{"key":"3775_CR37","first-page":"4072319","volume":"2019","author":"H Li","year":"2019","unstructured":"Li, H., Zhu, R., Zhao, R., Qian, L. & Jiang, L. Role of Tgf-Beta1\/Smad2\/3 Pathway in Retinal Outer Deep Vascular Plexus and Photoreceptor Damage in Rat 50\/10 Oxygen-Induced Retinopathy. Biomed. Res Int 2019, 4072319 (2019).","journal-title":"Biomed. Res Int"},{"key":"3775_CR38","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1167\/iovs.09-3619","volume":"50","author":"A Basu","year":"2009","unstructured":"Basu, A., Menicucci, G., Maestas, J., Das, A. & McGuire, P. Plasminogen Activator Inhibitor-1 (Pai-1) Facilitates Retinal Angiogenesis in a Model of Oxygen-Induced Retinopathy. Invest Ophthalmol. Vis. Sci. 50, 4974\u20134981 (2009).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"3775_CR39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/jop.2014.0151","volume":"31","author":"P Fei","year":"2015","unstructured":"Fei, P. et al. Thrombospondin-2 Expression During Retinal Vascular Development and Neovascularization. J. Ocul. Pharm. Ther. 31, 429\u2013444 (2015).","journal-title":"J. Ocul. Pharm. Ther."},{"key":"3775_CR40","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/ATVBAHA.121.315941","volume":"41","author":"G De Rossi","year":"2021","unstructured":"De Rossi, G. et al. Pathological Angiogenesis Requires Syndecan-4 for Efficient Vegfa-Induced Ve-Cadherin Internalization. Arterioscler Thromb. Vasc. Biol. 41, 1374\u20131389 (2021).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"3775_CR41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1055-3207(18)30072-3","volume":"10","author":"SA Rabbani","year":"2001","unstructured":"Rabbani, S. A. & Mazar, A. P. The Role of the Plasminogen Activation System in Angiogenesis and Metastasis. Surg. Oncol. Clin. N. Am. 10, 393\u2013415, x (2001).","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"3775_CR42","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1167\/iovs.16-19617","volume":"57","author":"D Ozone","year":"2016","unstructured":"Ozone, D. et al. Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Laser-Induced Choroidal Neovascularization in Mice. Invest Ophthalmol. Vis. Sci. 57, 5348\u20135354 (2016).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"3775_CR43","first-page":"1172","volume":"42","author":"H Ishihama","year":"2001","unstructured":"Ishihama, H. et al. Colocalization of Neuropilin-1 and Flk-1 in Retinal Neovascularization in a Mouse Model of Retinopathy. Invest Ophthalmol. Vis. Sci. 42, 1172\u20131178 (2001).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"3775_CR44","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1042\/BST20140244","volume":"42","author":"A Lampropoulou","year":"2014","unstructured":"Lampropoulou, A. & Ruhrberg, C. Neuropilin Regulation of Angiogenesis. Biochem Soc. Trans. 42, 1623\u20131628 (2014).","journal-title":"Biochem Soc. Trans."},{"key":"3775_CR45","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.102.16.1931","volume":"102","author":"M Merten","year":"2000","unstructured":"Merten, M. & Thiagarajan, P. P-Selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates. Circulation 102, 1931\u20131936 (2000).","journal-title":"Circulation"},{"key":"3775_CR46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1055\/s-0038-1656093","volume":"77","author":"D Rajasekhar","year":"1997","unstructured":"Rajasekhar, D., Barnard, M. R., Bednarek, F. J. & Michelson, A. D. Platelet Hyporeactivity in Very Low Birth Weight Neonates. Thromb. Haemost. 77, 1002\u20131007 (1997).","journal-title":"Thromb. Haemost."},{"key":"3775_CR47","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1189\/jlb.0805448","volume":"79","author":"K Egami","year":"2006","unstructured":"Egami, K., Murohara, T., Aoki, M. & Matsuishi, T. Ischemia-Induced Angiogenesis: Role of Inflammatory Response Mediated by P-Selectin. J. Leukoc. Biol. 79, 971\u2013976 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"3775_CR48","first-page":"3s","volume":"26","author":"A Lubkowska","year":"2012","unstructured":"Lubkowska, A., Dolegowska, B. & Banfi, G. Growth Factor Content in Prp and Their Applicability in Medicine. J. Biol. Regul. Homeost. Agents 26, 3s\u201322s (2012).","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"3775_CR49","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. Angiogenesis in Life, Disease and Medicine. Nature 438, 932\u2013936 (2005).","journal-title":"Nature"},{"key":"3775_CR50","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1410689","volume":"372","author":"MA Rysavy","year":"2015","unstructured":"Rysavy, M. A. et al. Between-Hospital Variation in Treatment and Outcomes in Extremely Preterm Infants. N. Engl. J. Med 372, 1801\u20131811 (2015).","journal-title":"N. Engl. J. Med"},{"key":"3775_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","volume":"63","author":"S Selvam","year":"2018","unstructured":"Selvam, S., Kumar, T. & Fruttiger, M. Retinal Vasculature Development in Health and Disease. Prog. Retin Eye Res 63, 1\u201319 (2018).","journal-title":"Prog. Retin Eye Res"},{"key":"3775_CR52","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)63214-2","volume":"164","author":"JL Wilkinson-Berka","year":"2004","unstructured":"Wilkinson-Berka, J. L. et al. Inhibition of Platelet-Derived Growth Factor Promotes Pericyte Loss and Angiogenesis in Ischemic Retinopathy. Am. J. Pathol. 164, 1263\u20131273 (2004).","journal-title":"Am. J. Pathol."},{"key":"3775_CR53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000487054","volume":"59","author":"KI Arai","year":"2018","unstructured":"Arai, K. I. et al. Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Corneal Neovascularization in Rabbits. Ophthalmic Res 59, 170\u2013175 (2018).","journal-title":"Ophthalmic Res"},{"key":"3775_CR54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/14653241003588858","volume":"13","author":"NF Siddiqui","year":"2011","unstructured":"Siddiqui, N. F., Shabrani, N. C., Kale, V. P. & Limaye, L. S. Enhanced Generation of Megakaryocytes from Umbilical Cord Blood-Derived Cd34(+) Cells Expanded in the Presence of Two Nutraceuticals, Docosahexanoic Acid and Arachidonic Acid, as Supplements to the Cytokine-Containing Medium. Cytotherapy 13, 114\u2013128 (2011).","journal-title":"Cytotherapy"},{"key":"3775_CR55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11745-997-0055-7","volume":"32","author":"GJ Nelson","year":"1997","unstructured":"Nelson, G. J., Schmidt, P. C., Bartolini, G., Kelley, D. S. & Kyle, D. The Effect of Dietary Arachidonic Acid on Platelet Function, Platelet Fatty Acid Composition, and Blood Coagulation in Humans. Lipids 32, 421\u2013425 (1997).","journal-title":"Lipids"},{"key":"3775_CR56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s11745-997-0145-6","volume":"32","author":"GJ Nelson","year":"1997","unstructured":"Nelson, G. J., Schmidt, P. S., Bartolini, G. L., Kelley, D. S. & Kyle, D. The Effect of Dietary Docosahexaenoic Acid on Platelet Function, Platelet Fatty Acid Composition, and Blood Coagulation in Humans. Lipids 32, 1129\u20131136 (1997).","journal-title":"Lipids"},{"key":"3775_CR57","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/apa.15406","volume":"109","author":"P Lundgren","year":"2020","unstructured":"Lundgren, P. et al. Association between Low Fatty Acid Levels and Platelet Count in Infants with Retinopathy of Prematurity. Acta Paediatr. 109, 2547\u20132548 (2020).","journal-title":"Acta Paediatr."},{"key":"3775_CR58","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2018-02-831503","volume":"132","author":"S Lepropre","year":"2018","unstructured":"Lepropre, S. et al. Ampk-Acc Signaling Modulates Platelet Phospholipids and Potentiates Thrombus Formation. Blood 132, 1180\u20131192 (2018).","journal-title":"Blood"},{"key":"3775_CR59","doi-asserted-by":"crossref","first-page":"C207","DOI":"10.1152\/ajpcell.00579.2008","volume":"297","author":"SH Lee","year":"2009","unstructured":"Lee, S. H., Kim, M. H. & Han, H. J. Arachidonic Acid Potentiates Hypoxia-Induced Vegf Expression in Mouse Embryonic Stem Cells: Involvement of Notch, Wnt, and Hif-1alpha. Am. J. Physiol. Cell Physiol. 297, C207\u2013C216 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"3775_CR60","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1073\/pnas.76.8.4107","volume":"76","author":"BL Linder","year":"1979","unstructured":"Linder, B. L., Chernoff, A., Kaplan, K. L. & Goodman, D. S. Release of Platelet-Derived Growth Factor from Human Platelets by Arachidonic Acid. Proc. Natl. Acad. Sci. USA 76, 4107\u20134111 (1979).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3775_CR61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.siny.2016.08.009","volume":"22","author":"DT Robinson","year":"2017","unstructured":"Robinson, D. T. & Martin, C. R. Fatty Acid Requirements for the Preterm Infant. Semin Fetal Neonatal Med 22, 8\u201314 (2017).","journal-title":"Semin Fetal Neonatal Med"},{"key":"3775_CR62","doi-asserted-by":"crossref","first-page":"1032s","DOI":"10.1093\/ajcn\/66.4.1032S","volume":"66","author":"MA Crawford","year":"1997","unstructured":"Crawford, M. A. et al. Are Deficits of Arachidonic and Docosahexaenoic Acids Responsible for the Neural and Vascular Complications of Preterm Babies? Am. J. Clin. Nutr. 66, 1032s\u20131041s (1997).","journal-title":"Am. J. Clin. Nutr."},{"issue":"Suppl 1","key":"3775_CR63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000448265","volume":"69","author":"A Lapillonne","year":"2016","unstructured":"Lapillonne, A. & Moltu, S. J. Long-Chain Polyunsaturated Fatty Acids and Clinical Outcomes of Preterm Infants. Ann. Nutr. Metab. 69(Suppl 1), 35\u201344 (2016).","journal-title":"Ann. Nutr. Metab."},{"key":"3775_CR64","first-page":"708","volume":"28","author":"PC Fang","year":"2005","unstructured":"Fang, P. C. et al. The Effect of Supplementation of Docosahexaenoic Acid and Arachidonic Acid on Visual Acuity and Neurodevelopment in Larger Preterm Infants. Chang Gung Med J. 28, 708\u2013715 (2005).","journal-title":"Chang Gung Med J."},{"key":"3775_CR65","volume":"32","author":"P Lundgren","year":"2023","unstructured":"Lundgren, P. et al. Visual Outcome at 2.5 Years of Age in \u03a9-3 and \u03a9-6 Long-Chain Polyunsaturated Fatty Acid Supplemented Preterm Infants: A Follow-up of a Randomized Controlled Trial. Lancet Reg. Health Eur. 32, 100696 (2023).","journal-title":"Lancet Reg. Health Eur."},{"key":"3775_CR66","doi-asserted-by":"crossref","unstructured":"Fang, J. L. et al. Interventions to Prevent Retinopathy of Prematurity: A Meta-Analysis. Pediatrics 137, e20153387 (2016).","DOI":"10.1542\/peds.2015-3387"},{"key":"3775_CR67","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-0036-1597131","volume":"34","author":"S Vayalthrikkovil","year":"2017","unstructured":"Vayalthrikkovil, S. et al. Parenteral Fish-Oil Lipid Emulsions in the Prevention of Severe Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. Am. J. Perinatol. 34, 705\u2013715 (2017).","journal-title":"Am. J. Perinatol."},{"key":"3775_CR68","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0148607113499373","volume":"38","author":"D Pawlik","year":"2014","unstructured":"Pawlik, D., Lauterbach, R., Walczak, M., Hurka\u0142a, J. & Sherman, M. P. Fish-Oil Fat Emulsion Supplementation Reduces the Risk of Retinopathy in Very Low Birth Weight Infants: A Prospective, Randomized Study. JPEN J. Parenter. Enter. Nutr. 38, 711\u2013716 (2014).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"3775_CR69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.earlhumdev.2013.11.002","volume":"90","author":"S Beken","year":"2014","unstructured":"Beken, S. et al. The Influence of Fish-Oil Lipid Emulsions on Retinopathy of Prematurity in Very Low Birth Weight Infants: A Randomized Controlled Trial. Early Hum. Dev. 90, 27\u201331 (2014).","journal-title":"Early Hum. Dev."},{"key":"3775_CR70","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jpen.1497","volume":"43","author":"M Bernabe-Garc\u00eda","year":"2019","unstructured":"Bernabe-Garc\u00eda, M. et al. Enteral Docosahexaenoic Acid and Retinopathy of Prematurity: A Randomized Clinical Trial. JPEN. J. Parenter. Enter. Nutr. 43, 874\u2013882 (2019).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"3775_CR71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clnu.2023.11.037","volume":"43","author":"SJ Moltu","year":"2024","unstructured":"Moltu, S. J. et al. Arachidonic and Docosahexaenoic Acid Supplementation and Brain Maturation in Preterm Infants; a Double Blind Rct. Clin. Nutr. 43, 176\u2013186 (2024).","journal-title":"Clin. Nutr."},{"key":"3775_CR72","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00431-016-2755-1","volume":"175","author":"C Henriksen","year":"2016","unstructured":"Henriksen, C. et al. Growth, Metabolic Markers, and Cognition in 8-Year Old Children Born Prematurely, Follow-up of a Randomized Controlled Trial with Essential Fatty Acids. Eur. J. Pediatr. 175, 1165\u20131174 (2016).","journal-title":"Eur. J. Pediatr."},{"key":"3775_CR73","doi-asserted-by":"crossref","first-page":"e2128771","DOI":"10.1001\/jamanetworkopen.2021.28771","volume":"4","author":"A Hellstr\u00f6m","year":"2021","unstructured":"Hellstr\u00f6m, A. et al. Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels with Retinopathy of Prematurity in Preterm Infants. JAMA Netw. Open 4, e2128771 (2021).","journal-title":"JAMA Netw. Open"},{"key":"3775_CR74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamaophthalmol.2017.6658","volume":"136","author":"CA L\u00f6fqvist","year":"2018","unstructured":"L\u00f6fqvist, C. A. et al. Association of Retinopathy of Prematurity with Low Levels of Arachidonic Acid: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 136, 271\u2013277 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"3775_CR75","doi-asserted-by":"crossref","unstructured":"Fu, Z. et al. Omega-3\/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity. Nutrients 14, 1333 (2022).","DOI":"10.3390\/nu14071333"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03775-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03775-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03775-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T08:49:49Z","timestamp":1758530989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03775-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3775"],"URL":"https:\/\/doi.org\/10.1038\/s41390-024-03775-3","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent was retrieved from the participating infant\u2019s guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}